Canadian Regulatory Affairs required updates to the Instructions for Use (IFU) for Sunlenca (Lenacapavir). The IFU format was previously a booklet with English on one side and French on the other. The artwork template was updated so the IFU was now a single double-sided card, reducing the amount of material needed for conveying the same amount of information.
